Trial Profile
A proof-of-concept trial of entrectinib in cancer patients with metastatic melanoma
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 08 Jul 2015
Price :
$35
*
At a glance
- Drugs Entrectinib (Primary)
- Indications Malignant melanoma
- Focus Proof of concept; Therapeutic Use
- 08 Jul 2015 New trial record